Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Table of Contents Understanding the Problem: What Payer Underpayment Actually Lo...
There are tears in the audience as Patrick Darling’s song begins to play. It’s a...
The Smart Messaging Tool helps clinicians better manage patient messages and add...
Pharmacy benefit managers (PBMs) were identified as a major driver behind higher...
Over the past year, Jim O’Neill has become one of the most powerful people in pu...
Americans have a new set of diet guidelines. Robert F. Kennedy Jr. has taken an ...
The move is part of Ampersand’s strategy to establish a trans-Atlantic pharmaceu...
This approval provides a new option for long-term disease control in patients, w...
Pharmacy benefit managers (PBMs) were identified as a major driver behind higher...
Akums Drugs & Pharmaceuticals has received its first product approval from the ...
Arjit Agarwal, Principal Consultant, Business Consulting, Nexdigm highlights th...
Kishan Kumar, MBA Graduate Student, Southern Connecticut State University, US p...
An engaging Plenary discussion on India’s Path to Biopharmaceutical Leadership:...
For adults with chronic disease, regular primary care access reduces health cost...
The agreement focuses on expanding Lymphir’s international access via country-sp...
The therapies are approved as second or third line treatment for adults with pla...
